Oncology
 |
|
11 february 2019 01:00:04 |
| MST1/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trial (British Journal of Cancer) |
|
Tweet |
| 71 viewsCategory: Oncology |
 Inhibition of SIRT1 deacetylase and p53 activation uncouples the anti-inflammatory and chemopreventive actions of NSAIDs (British Journal of Cancer)The induction of core pluripotency master regulators in cancers defines poor clinical outcomes and treatment resistance (Oncogene) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
